Earnings Releases·Nov 5, 2026, 8:10 AM ET

Charles River Associates — Third Quarter 2026 Earnings Summary

Full-year fiscal 2026 revenue guidance increased to $830–$840 million (constant currency), and non-GAAP EBITDA margin guidance narrowed to 12.2–12.8%, reflecting strong third-quarter performance where revenue rose 15.6% YoY to $214.9 million and net income grew 21.2% to $13.9 million.
Capital allocation strategy advanced with a 17.5% increase in the quarterly cash dividend to $0.67 per share and $49.3 million in common stock repurchases year-to-date, alongside a $15 million expected increase in non-cash forgivable loan amortization to fund talent investments.
Growth was broad-based across seven practices representing 95% of Q3 revenue, with double-digit growth in Forensic Services, Life Sciences, and Risk, Investigations & Analytics, while North American operations surged 18.0% YoY.
Management cited record third-quarter profits and best-ever year-to-date revenue and non-GAAP EBITDA, though noted risks from macroeconomic uncertainty, competitive pricing, and artificial intelligence developments.